Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii

SummaryBackgroundOver the last 10 years, multidrug resistant Acinetobacter baumannii has been spreading worldwide as emerging microorganisms that negatively impact on the outcome of in-hospital patients.MethodsBetween 2007 and 2016, all isolates of patients of the Vienna General Hospital (VGH), tested positive for multidrug resistant Acinetobacter baumannii (MDR A. baumannii) strains, were investigated with respect to their genetic relationship. Patient medical histories were reviewed in order to collect discriminating factors related to MDR A. baumannii colonization or infection.ResultsA total of 79 isolates of 76 patients were obtained. For 44 of them (55.7%) the first diagnosis ward was an intensive care unit (ICU). A total of 10 genotype clusters were identified and 35 cases (44.3%) of in-hospital acquisition in our institution could be detected. Multidrug resistant Acinetobacter baumannii isolates were acquired before admission to our hospital in 44 cases (55.7%) and in 31 (70.5%) they belonged to patients who had previous exposure to the healthcare setting of high prevalence countries for MDR A. baumannii.ConclusionPatients admitted to our hospital with a previous healthcare contact in a high prevalence country for multidrug resistant Acinetobacter baumannii should be screened before admission to high-risk wards. Isolation of these patients until microbiological results could reduce negative outcome in these wards.

• Publication year

  2017

• Venue

  Wiener Klinische Wochenschrift

• Publication date

  2017-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00508-017-1242-7PMID 28776101PMCID 5676840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

  2016cited by this paper
• Emergence of antimicrobial resistance among Acinetobacter species: a global threat

  2016cited by this paper
• Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened?

  2015cited by this paper
• European Centre for Disease Prevention and Control.

  2014cited by this paper
• The role of the surface environment in healthcare-associated infections

  2013cited by this paper
• Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome.

  2012cited by this paper
• Gram-negative osteomyelitis: clinical and microbiological profile.

  2012cited by this paper
• Country-to-country transfer of patients and the risk of multi-resistant bacterial infection.

  2011cited by this paper
• Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread.

  2011cited by this paper
• Central nervous system infections in patients with severe burns.

  2010cited by this paper
• Acinetobacter baumannii: Emergence of a Successful Pathogen

  2008cited by this paper
• Cross-Transmission of Multidrug-Resistant Acinetobacter baumannii Clonal Strains Causing Episodes of Sepsis in a Trauma Intensive Care Unit

  2008cited by this paper
• Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

  2008cited by this paper
• CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

  2008cited by this paper
• BMC Infectious Diseases BioMed Central Research article

  2007cited by this paper
• Global Challenge of Multidrug-Resistant Acinetobacter baumannii

  2007cited by this paper
• An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

  2007cited by this paper
• [Structure of the Surveillance and management of infectious diseases in the European Union. The EU surveillance networks and the European Centre for Disease Prevention und Control (ECDC)].

  2005cited by this paper
• Clinical impact and pathogenicity of Acinetobacter.

  2005cited by this paper
• Early prosthetic valve endocarditis due to Acinetobacter baumannii: A case report and brief review of the literature

  2005cited by this paper
• Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands.

  2004cited by this paper
• Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

  2002cited by this paper
• Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features

  1996cited by this paper
• CDC definitions for nosocomial infections.

  1989cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper

• From resistance to treatment: the ongoing struggle with Acinetobacter baumannii

  2025cites this paper
• Global Risk Maps of Climate Change Impacts on the Distribution of Acinetobacter baumannii Using GIS

  2023cites this paper
• Microbial Air Quality in Healthcare Facilities

  2021cites this paper
• Molecular epidemiology of carbapenem‐resistant Acinetobacter baumannii isolated from three major hospitals in Jordan

  2021cites this paper
• Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria

  2021cites this paper
• A Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil

  2020cites this paper
• PECULIARITIES OF RECOMBINATIVE GENOMICS OF ACINETOBACTER — HUMAN PATHOGEN

  2019cites this paper
• Studies on the effect of biogenic stimulators on growth of bacterial cultures

  2019cites this paper
• Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii

  2019cites this paper